Isolec 1 (Sodium Chloride 0.9% w/v Intravenous Infusion B.P. (Vet))

Summary of Product characteristics

                                AN:00121/2013
Revised: June 2013 SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Isolec 1 (Sodium Chloride 0.9 % w/v Intravenous Infusion BP (Vet))
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Sodium Chloride
0.9 % w/v
Approximate ionic content in millimoles per litre:
Sodium
150 mmol/L
Chloride
150 mmol/L
3.
PHARMACEUTICAL FORM
Solution for infusion.
Clear, colourless solution for infusion.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, calves, horses, dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
This product is administered by intravenous infusion for the treatment
of
dehydration in cattle, calves, horses, dogs and cats. It may be used
to correct
hypovolaemia resulting from shock or gastrointestinal disease
(especially
where metabolic alkalosis is present, e.g. in cases of sustained
vomiting or
abomasal disorders in cattle). It may be administered to meet normal
fluid and
electrolyte requirements when fluids cannot be given orally.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Page 1 of 5
AN:00121/2013
Revised: June 2013
4.5 SPECIAL PRECAUTIONS FOR USE
i Special precautions for use in animals
Sodium overload may occur in animals with cardiac or renal
impairment. It should be noted that sodium excretion may be
impaired post-surgery/trauma.
A risk of thrombosis with intravenous infusion should be considered.
The product should be warmed to approximately 37
°
C prior to the
administration of large volumes, or if the administration rate is
high,
in order to avoid hypothermia.
This product should not be used for longer than is necessary to
correct and sustain circulating volume. Inappropriate/excessive use
may worsen or create a metabolic acidosis.
Maintain aseptic precautions.
ii Special precautions to be taken by the person administering the
veterinary medicinal product to animals
No special precautions required.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Excessive infusion rates can cause restlessness, moist lung s
                                
                                Read the complete document